levodopa/carbidopa low dose (ND0612L) / Mitsubishi Tanabe  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
levodopa/carbidopa low dose (ND0612L) / Mitsubishi Tanabe
NCT02604914: A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects

Completed
1
36
Europe
ND0612, (Levodopa-Carbidopa solution), LCIG, (Levodopa-Carbidopa Intestinal Gel)
NeuroDerm Ltd., Quotient Clinical
Parkinson's Disease
06/16
06/16

Download Options